Overview Fundamentals API Earnings EOD API Sample Code Pricing

bioAffinity Technologies Inc. (BIAF NASDAQ) stock market data APIs

$2.81 0.1(3.7%) as of July 26, 2024
Price chart is built with Anychart

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.

bioAffinity Technologies Inc. Financial Data Overview

2.71
2.81
-
2.81
2.66
0.9548-3.62
30 444 K
11 360 K
4 938 K
-0.2567
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BIAF',
Type: 'Common Stock',
Name: 'bioAffinity Technologies Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00H69JDX1',
ISIN: NULL,
CUSIP: NULL,
CIK: '0001712762',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2022-09-01',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
HomeCategory: NULL,
IsDelisted: false,
}

bioAffinity Technologies Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 938 K
  • EBITDA -7 854 619
  • Earnings Per Share -0.93
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get bioAffinity Technologies Inc. Earnings via APIs

  • Latest Release 2024-05-13
  • EPS/Forecast -0.2

Get bioAffinity Technologies Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com